Meningococcal C Vaccine Can Provide Lasting Protection

"The meningococcal C vaccine program introduced in the UK in 1999 has been successful in controlling the incidence of serogroup C disease. Now, new research indicates that vaccine effectiveness remains high 4 years later, provided that the vaccine was administered at the appropriate age."